Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to evaluate the safety and tolerability of SUN13837 and to determine whether SUN13837 improves the physical performance, relative to placebo, following an acute stroke in adult subjects. Trial Stopped: study was stopped for business/administrative reasons and not for patient safety concerns

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 October 2015.

1 Sep 2014 29 Sep 2014 1 May 2016 1 May 2016 1 Oct 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Intervention: Parallel Assignment